ORCHESTRA

A Double-Blind, Placebo-Controlled, Randomized, 18-month Phase 2A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmakokinetics of oral UCB0599 in Study Participants with early-stage Parkinson's Disease.

For further information on the Orchestra Study, please visit orchestra-study.com.

Status: recruitment completed